Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
The purpose of this study is to evaluate the safety and efficacy of targeted cryoablation therapy for hepatic carcinoma.
Liver Neoplasms
PROCEDURE: Targeted Cryoablation Therapy
Rate of complete tumor ablation, Up to 4 weeks post surgery
Adverse Events, Up to 4 weeks post surgery
A cryoprobe is inserted percutaneously under CT guidance into the targeted lesion. Patients undergo ablation using a freeze-thaw-freeze cycle lasting approximately 10-6-10minutes.